| scholarly article | Q13442814 |
| P2093 | author name string | Toshiyuki Tanaka | |
| Aya Tanaka | |||
| Sachiyo Yoshida | |||
| Yuta Shimizu | |||
| Saya Tanaka | |||
| Kazuma Sakura | |||
| Yuki Yamawaki | |||
| Yoshiya Ohno | |||
| Ai Yoshifuji | |||
| Sakina Miyake | |||
| Sena Fudesaka | |||
| Serina Shingyoku | |||
| P2860 | cites work | 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. | Q39872948 |
| Akt Signaling Is Sustained by a CD44 Splice Isoform-Mediated Positive Feedback Loop | Q41546742 | ||
| Low molecular weight hyaluronan induces malignant mesothelioma cell (MMC) proliferation and haptotaxis: role of CD44 receptor in MMC proliferation and haptotaxis. | Q44188326 | ||
| Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production | Q46409730 | ||
| Activin pathway enhances colorectal cancer stem cell self-renew and tumor progression | Q49018681 | ||
| Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study. | Q51509080 | ||
| Overexpression of activin-A and -B in malignant mesothelioma - attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth. | Q52978477 | ||
| Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. | Q53279352 | ||
| Malignant mesothelioma | Q80961479 | ||
| Effects of hyaluronic acid and CD44 interaction on the proliferation and invasiveness of malignant pleural mesothelioma | Q84780390 | ||
| Eyes wide open: a critical review of sphere-formation as an assay for stem cells | Q24631827 | ||
| The epithelial-mesenchymal transition generates cells with properties of stem cells | Q24650786 | ||
| ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome | Q24657877 | ||
| New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas | Q26859274 | ||
| The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy | Q27314606 | ||
| Activin receptor-like kinases: a diverse family playing an important role in cancer | Q28066886 | ||
| Intertwining of Activin A and TGFβ Signaling: Dual Roles in Cancer Progression and Cancer Cell Invasion | Q28082707 | ||
| Cancer stem cells in solid tumours: accumulating evidence and unresolved questions | Q28293535 | ||
| Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents | Q28546911 | ||
| Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group. | Q33390867 | ||
| CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives | Q33556551 | ||
| Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship | Q34193347 | ||
| Tackling the cancer stem cells - what challenges do they pose? | Q34523263 | ||
| Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity. | Q35177969 | ||
| Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice | Q36362323 | ||
| Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells | Q36451785 | ||
| Mechanisms of chemoresistance in cancer stem cells | Q36591484 | ||
| A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer | Q37706944 | ||
| CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? | Q37851351 | ||
| Molecular pathogenesis of malignant mesothelioma | Q38107102 | ||
| Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation | Q38655714 | ||
| Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis | Q38735799 | ||
| Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations | Q38790079 | ||
| Carcinoma Cell Hyaluronan as a "Portable" Cancerized Prometastatic Microenvironment. | Q38838567 | ||
| SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells | Q39454272 | ||
| Novel insights into mesothelioma biology and implications for therapy. | Q39455555 | ||
| Identification of cancer stem cell markers in human malignant mesothelioma cells | Q39619424 | ||
| Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells. | Q39747942 | ||
| P433 | issue | 49 | |
| P304 | page(s) | 6357-6367 | |
| P577 | publication date | 2018-07-30 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways | |
| P478 | volume | 37 |
| Q90910771 | Enhanced hexosamine metabolism drives metabolic and signaling networks involving hyaluronan production and O-GlcNAcylation to exacerbate breast cancer | cites work | P2860 |
Search more.